290 related articles for article (PubMed ID: 21390155)
1. BALB/c mice infected with antimony treatment refractory isolate of Leishmania braziliensis present severe lesions due to IL-4 production.
Costa DL; Carregaro V; Lima-Júnior DS; Silva NM; Milanezi CM; Cardoso CR; Giudice Â; de Jesus AR; Carvalho EM; Almeida RP; Silva JS
PLoS Negl Trop Dis; 2011 Mar; 5(3):e965. PubMed ID: 21390155
[TBL] [Abstract][Full Text] [Related]
2. CXCL10 immunomodulatory effect against infection caused by an antimony refractory isolate of Leishmania braziliensis in mice.
Dutra BM; Rodrigues NLC; Fonseca FRM; de Moura TR; Pacheco de Almeida R; de Jesus AR; Abreu TM; Pompeu MML; Teixeira CR; Teixeira MJ
Parasite Immunol; 2021 Mar; 43(3):e12805. PubMed ID: 33131089
[TBL] [Abstract][Full Text] [Related]
3. Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production.
Souza AS; Giudice A; Pereira JM; Guimarães LH; de Jesus AR; de Moura TR; Wilson ME; Carvalho EM; Almeida RP
BMC Infect Dis; 2010 Jul; 10():209. PubMed ID: 20633260
[TBL] [Abstract][Full Text] [Related]
4. Intraspecies susceptibility of Leishmania (Viannia) braziliensis to antileishmanial drugs: Antimony resistance in human isolates from atypical lesions.
Rugani JN; Quaresma PF; Gontijo CF; Soares RP; Monte-Neto RL
Biomed Pharmacother; 2018 Dec; 108():1170-1180. PubMed ID: 30372818
[TBL] [Abstract][Full Text] [Related]
5. Leishmania braziliensis isolates differing at the genome level display distinctive features in BALB/c mice.
Indiani de Oliveira C; Teixeira MJ; Teixeira CR; Ramos de Jesus J; Bomura Rosato A; Santa da Silva J; Brodskyn C; Barral-Netto M; Barral A
Microbes Infect; 2004 Sep; 6(11):977-84. PubMed ID: 15345228
[TBL] [Abstract][Full Text] [Related]
6. Development of real-time PCR assays for evaluation of immune response and parasite load in golden hamster (Mesocricetus auratus) infected by Leishmania (Viannia) braziliensis.
Ribeiro-Romão RP; Saavedra AF; Da-Cruz AM; Pinto EF; Moreira OC
Parasit Vectors; 2016 Jun; 9(1):361. PubMed ID: 27350537
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients.
Silva SC; Guimarães LH; Silva JA; Magalhães V; Medina L; Queiroz A; Machado PRL; Schriefer A
Acta Trop; 2018 Feb; 178():34-39. PubMed ID: 29042262
[TBL] [Abstract][Full Text] [Related]
8. A Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment Outcome.
Coelho AC; Oliveira JC; Espada CR; Reimão JQ; Trinconi CT; Uliana SR
PLoS Negl Trop Dis; 2016 May; 10(5):e0004660. PubMed ID: 27144739
[TBL] [Abstract][Full Text] [Related]
9. A Cytokine Network Balance Influences the Fate of
Paiva MB; Ribeiro-Romão RP; Resende-Vieira L; Braga-Gomes T; Oliveira MP; Saavedra AF; Silva-Couto L; Albuquerque HG; Moreira OC; Pinto EF; Da-Cruz AM; Gomes-Silva A
Front Immunol; 2021; 12():656919. PubMed ID: 34276650
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis.
Barral A; Barral-Netto M; Yong EC; Brownell CE; Twardzik DR; Reed SG
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3442-6. PubMed ID: 7682701
[TBL] [Abstract][Full Text] [Related]
11. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
[TBL] [Abstract][Full Text] [Related]
12. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.
Costa IS; de Souza GF; de Oliveira MG; Abrahamsohn Ide A
J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476
[TBL] [Abstract][Full Text] [Related]
13. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.
Gomes RS; Silva MVT; Dos Santos JC; de Lima Silva LL; Batista AC; Machado JR; Teixeira MM; Dorta ML; de Oliveira MAP; Dinarello CA; Joosten LAB; Ribeiro-Dias F
Parasit Vectors; 2017 Jul; 10(1):336. PubMed ID: 28709468
[TBL] [Abstract][Full Text] [Related]
14. Leishmania infantum induces high phagocytic capacity and intracellular nitric oxide production by human proinflammatory monocyte.
Ribeiro CV; Rocha BFB; Oliveira E; Teixeira-Carvalho A; Martins-Filho OA; Murta SMF; Peruhype-Magalhães V
Mem Inst Oswaldo Cruz; 2020; 115():e190408. PubMed ID: 32321156
[TBL] [Abstract][Full Text] [Related]
15. Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.
Rocha FJ; Schleicher U; Mattner J; Alber G; Bogdan C
Infect Immun; 2007 Aug; 75(8):3823-32. PubMed ID: 17517868
[TBL] [Abstract][Full Text] [Related]
16. Impaired Th1 Response Is Associated With Therapeutic Failure in Patients With Cutaneous Leishmaniasis Caused by Leishmania braziliensis.
Carvalho AM; Guimarães LH; Costa R; Saldanha MG; Prates I; Carvalho LP; Arruda S; Carvalho EM
J Infect Dis; 2021 Feb; 223(3):527-535. PubMed ID: 32620011
[TBL] [Abstract][Full Text] [Related]
17. Salivary gland homogenates from wild-caught sand flies Lutzomyia flaviscutellata and Lutzomyia (Psychodopygus) complexus showed inhibitory effects on Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis infection in BALB/c mice.
Francesquini FC; Silveira FT; Passero LF; Tomokane TY; Carvalho AK; Corbett CE; Laurenti MD
Int J Exp Pathol; 2014 Dec; 95(6):418-26. PubMed ID: 25476864
[TBL] [Abstract][Full Text] [Related]
18. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis.
Silveira FT; Lainson R; De Castro Gomes CM; Laurenti MD; Corbett CE
Parasite Immunol; 2009 Aug; 31(8):423-31. PubMed ID: 19646206
[TBL] [Abstract][Full Text] [Related]
19. The F1F3 Recombinant Chimera of
Alves-Silva MV; Nico D; de Luca PM; Palatnik de-Sousa CB
Front Immunol; 2019; 10():724. PubMed ID: 31024556
[No Abstract] [Full Text] [Related]
20. Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody.
Heinzel FP; Maier RA
Infect Immun; 1999 Dec; 67(12):6454-60. PubMed ID: 10569763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
